C.D.C. (Europe)

Throughout 2023, ECDC and its partner countries collaborated to strengthen the regional workforce as part of the EU Initiative on Health Security. The goal was to enhance capacities for addressing communicable diseases in both EU enlargement countries and those participating in the EU Neighbourhood Policy (ENP).

World Tuberculosis Day, marked each year on 24 March, is an occasion to raise awareness and advocate for efforts to eliminate TB.

Veronica Cristea, Scientific Officer at ECDC, discusses the overall TB situation in the EU/EEA, the impact of COVID-19, challenges in treatment success, and the concerning rise in TB cases among children.

In 2015, at 19 years old, Frida, from Norway, returned from a three-month backpacking trip feeling unwell. Initially misdiagnosed with pneumonia, it was only after mentioning her travels that she was tested for tuberculosis (TB).

The 2025 Tuberculosis surveillance and monitoring report shows that children under 15 years of age accounted for 4.3% of those with new and relapsed tuberculosis (TB) in the WHO European Region, representing a worrying 10% surge in paediatric TB for 2023.

With funding from the Africa CDC – ECDC Partnership, Imen Haddad recently participated in an ECDC workshop on infodemic management organised under the EU Initiative on Health Security.

The European Centre for Disease Prevention and Control (ECDC) is closely monitoring the situation following the tragic fire at the Pulse nightclub in Kočani, North Macedonia. Many patients with burn injuries are being transferred to hospitals across EU Member States and neighbouring countries for urgent medical care.

ECDC and Africa CDC are responsible for protecting almost 2 billion people from infectious diseases.

The European Centre for Disease Prevention and Control (ECDC) has published findings from its 2024 survey assessing public health workforce capacity in infectious disease prevention and control across European Union and European Economic Area (EU/EEA) countries.

From 5 to 7 March 2025, a technical team from ECDC visited Kosovo to discuss the country’s communicable disease surveillance system.

Data on measles cases in the European Union and European Economic Area (EU/EEA) for the last twelve months show a considerable rise in notifications compared to 2023.

The European Centre for Disease Prevention and Control (ECDC) is preparing for an impactful year in 2025, delivering training sessions, capacity-building initiatives, and enhancing collaboration with European Neighbourhood Policy (ENP) partner countries under the EU Initiative on Health Security.

Public health and food safety authorities across Europe are investigating prolonged and widespread outbreaks of Salmonella infection linked to the consumption of sprouted alfalfa seeds.

A cross-border multi-serovar Salmonella enterica outbreak linked to the consumption of sprouted seeds has been ongoing in Europe since 2023.

Recent surveillance data reveal that resistance to commonly used antimicrobials — such as ampicillin, tetracyclines, and sulfonamides— remains persistently high in both humans and animals for key pathogens including Salmonella and Campylobacter.

This report provides an overview of the total number of cases of mpox (monkeypox) reported to ECDC and the WHO Regional Office for Europe through IHR/EWRS mechanisms .

Between 24-28 February 2025, a team of experts from the European Commission, ECDC, EFSA, Epiconcept, the Integrated Quality Laboratory Services (IQLS), along with representatives from two EU Member States visited Serbia to discuss antimicrobial resistance (AMR) within a One Health perspective.

From 17 to 21 February 2025, the Robert Koch Institute in Berlin hosted the annual Multivariable Analysis (MVA) Module of the ECDC Fellowship Programme. The event brought together EPIET, EUPHEM, PAE, and MediPIET fellows and nominated external experts.

Thanas Goga is a specialist in Risk Communication, Community Engagement and Infodemic Management (RCCE-IM) at the WHO Health Emergencies Balkan Hub, WHO Regional Office for Europe.

While a recent study on a novel coronavirus in bats provides valuable laboratory characterisation data, it cannot be seen as evidence of an infection or transmission risk in humans.